Clinical trial of FK 506 immunosuppression in adult cardiac transplantation
John Fung
Annals of Thoracic Surgery, 1992
View PDFchevron_right
A clinical trial of FK 506 as primary and rescue immunosuppression in cardiac transplantation
John Fung
Transplantation proceedings, 1991
View PDFchevron_right
Superior rejection profile during the first 24 months after heart transplantation under tacrolimus as baseline immunosuppressive regimen
Arjang Ruhparwar, Christian Gleissner
Drug design, development and therapy, 2014
View PDFchevron_right
Long-term efficacy and safety of conversion to tacrolimus in heart transplant recipients with ongoing or recurrent acute cellular rejection
Miloš Kubánek
Physiological research / Academia Scientiarum Bohemoslovaca, 2010
View PDFchevron_right
Long-term Results of Tacrolimus Monotherapy in Cardiac Transplant Recipients
David Baran, Alan Gass
The Journal of Heart and Lung Transplantation, 2006
View PDFchevron_right
Optimizing the immunosuppressive regimen in heart transplantation
Howard Eisen
The Journal of Heart and Lung Transplantation, 2004
View PDFchevron_right
Superior Prevention of Acute Rejection by Tacrolimus vs. Cyclosporine in Heart Transplant Recipients-A Large European Trial
Massimo Maccherini
American Journal of Transplantation, 2006
View PDFchevron_right
A randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation: decreased hyperlipidemia and hypertension with tacrolimus 1 1 This study was sponsored by a grant from Fujisawa USA, Deerfield, Illinois. 2 2 The authors were working on beha...
david taylor
Journal of Heart and Lung Transplantation, 1999
View PDFchevron_right
The Treatment of Advanced Cardiac Allograft Rejection
Michael Sweeney
The Annals of Thoracic Surgery, 1988
View PDFchevron_right
Tacrolimus monotherapy in adult cardiac transplant recipients: intermediate-term results
John Fallon, Steven Lansman
The Journal of Heart and Lung Transplantation, 2001
View PDFchevron_right
Clinical results of steroid-free induction immunosuppression after heart transplantation
Giuseppe Faggian
Annals of Thoracic Surgery, 1993
View PDFchevron_right
Daclizumab to Prevent Rejection after Cardiac Transplantation
Howard Eisen
New England Journal of Medicine, 2005
View PDFchevron_right
Efficacy and Safety of de Novo and Early Use of Extended-release Tacrolimus in Heart Transplantation
Diego Rangel
Revista espanola de cardiologia (English ed.), 2017
View PDFchevron_right
Late Acute Cardiac Allograft Rejection: New Therapeutic Options?
Karlheinz Tscheliessnigg
Transplantation Proceedings, 2005
View PDFchevron_right
Efficacy of tacrolimus in the treatment of refractory rejection in heart and lung transplant recipients
Robert Love
Journal of Heart and Lung Transplantation, 1999
View PDFchevron_right
Induction therapy after cardiac transplantation: A comparison of anti-thymocyte globulin and daclizumab in the prevention of acute rejection
Henrik Arendrup
The Journal of Heart and Lung Transplantation, 2005
View PDFchevron_right
Incidence and Severity of Acute Cardiac Allograft Rejection with Two Different Low-Dose Cyclosporine Maintenance Protocols
gregor wollenek
The Annals of Thoracic Surgery, 1988
View PDFchevron_right
Heart transplantation-An update
Neta Blum
Clinical Cardiology, 1996
View PDFchevron_right
Two-Dose Daclizumab, Tacrolimus, Mycophenolate Mofetil, and Steroid-Free Regimen in De Novo Cardiac Transplant Recipients: Early Experience
Jesús Herreros
Transplantation Proceedings, 2007
View PDFchevron_right
Clinical outcome of heart transplant recipients receiving tacrolimus with or without mycophenolate mofetil
Florian Szabados
Clinical Transplantation, 2006
View PDFchevron_right
Effects of cyclosporine a monotherapy on the incidence of rejection and infection episodes in heart transplant patients
Adam Somlai-Fischer
Transplantation Proceedings, 1998
View PDFchevron_right
Five-Year Results of a Randomized, Single-Center Study of Tacrolimus vs Microemulsion Cyclosporine in Heart Transplant Patients
Brandy Oeser
The Journal of Heart and Lung Transplantation, 2006
View PDFchevron_right
Suggested guidelines for the use of tacrolimus in cardiac transplant recipients
Si Pham
The Journal of Heart and Lung Transplantation, 2001
View PDFchevron_right
The impact of tacrolimus as rescue therapy in children using a double immunosuppressive regimen after heart transplantation
carla tanamati
Transplantation proceedings, 2012
View PDFchevron_right
Basiliximab Versus Rabbit Antithymocyte Globulin for Induction Therapy in Patients After Heart Transplantation
Diego Delgado
Journal of Heart and Lung Transplantation, 2006
View PDFchevron_right
Influence of immunosuppressive regimens on short-term morbidity and mortality in heart transplantation
Rafael Rueda
Clinical Transplantation, 2007
View PDFchevron_right
Ten-year Follow-up of a Prospective, Randomized Trial of BT563/BB10 Versus Anti-thymocyte Globulin as Induction Therapy After Heart Transplantation
Alfred Kocher
The Journal of Heart and Lung Transplantation, 2006
View PDFchevron_right
Tacrolimus versus cyclosporine as primary immunosuppression after heart transplantation: systematic review with meta-analyses and trial sequential analyses of randomised trials
Finn Gustafsson, Christian Gluud
2010
View PDFchevron_right
FK 506 Suppression of Heart and Liver Allograft Rejection
John Fung
Transplantation, 1990
View PDFchevron_right
Conservative Management of Late Rejection After Heart Transplantation
jorge arturo salazar
Annals of Surgery, 1998
View PDFchevron_right